Literature DB >> 29078429

Troubleshooting hilar and interlobar lymphadenopathy during thoracoscopic lobectomy for benign disease-case report.

Sameer A Hirji1, Stafford S Balderson2, Thomas A D'Amico2.   

Abstract

The completion of thoracoscopic lobectomy can be more difficult in the setting of clinically positive lymph nodes, which may be found in the setting of a proximal tumor causing bronchial obstruction or a larger tumor which may create an inflammatory state, both of which cause benign significant enlargement of hilar lymph nodes. Knowledge of the typical locations of these enlarged nodes facilitates the conduct of the operation. For all video-assisted thoracoscopic surgery (VATS) lobectomies, it is prudent to remove all visible lymph nodes prior to arterial and bronchial dissection. Moreover, in cases of significant hilar adenopathy, this strategy becomes more important and effective. For left upper lobectomy, the removal of level 11 lymph node anteriorly improves visualization of both bronchi, the interlobar pulmonary artery, the arterial aspect of the fissure, and the lingular artery. Subsequent dissection of the level 10 lymph node superior to the upper lobe bronchus exposes the main pulmonary artery and the truncal branches. For right upper lobectomy, dissection of the level 11 lymph node posteriorly not only exposes the upper lobe bronchus, but also the adjacent posterior ascending pulmonary artery. Dissection of the level 10 lymph node at the superior hilum facilitates exposure of the right pulmonary artery.

Entities:  

Keywords:  Thoracoscopy; mediastinal lymph node dissection; video-assisted thoracoscopic surgery (VATS)

Year:  2016        PMID: 29078429      PMCID: PMC5637747          DOI: 10.3978/j.issn.2221-2965.2015.12.15

Source DB:  PubMed          Journal:  J Vis Surg        ISSN: 2221-2965


  6 in total

1.  Troubleshooting video-assisted thoracic surgery lobectomy.

Authors:  Todd L Demmy; Ted A James; Scott J Swanson; Robert J McKenna; Thomas A D'Amico
Journal:  Ann Thorac Surg       Date:  2005-05       Impact factor: 4.330

2.  Thoracoscopic lobectomy is a safe and versatile procedure: experience with 500 consecutive patients.

Authors:  Mark W Onaitis; Rebecca P Petersen; Stafford S Balderson; Eric Toloza; William R Burfeind; David H Harpole; Thomas A D'Amico
Journal:  Ann Surg       Date:  2006-09       Impact factor: 12.969

Review 3.  Long-term outcomes of thoracoscopic lobectomy.

Authors:  Thomas A D'Amico
Journal:  Thorac Surg Clin       Date:  2008-08       Impact factor: 1.750

Review 4.  Preoperative mediastinal lymph node staging for non-small cell lung cancer: 2014 update of the 2007 ESTS guidelines.

Authors:  Paul De Leyn; Christophe Dooms; Jaroslaw Kuzdzal; Didier Lardinois; Bernward Passlick; Ramon Rami-Porta; Akif Turna; Paul Van Schil; Frederico Venuta; David Waller; Walter Weder; Marcin Zielinski
Journal:  Transl Lung Cancer Res       Date:  2014-08

5.  Impact of T status and N status on perioperative outcomes after thoracoscopic lobectomy for lung cancer.

Authors:  Nestor R Villamizar; Marcus Darrabie; Jennifer Hanna; Mark W Onaitis; Betty C Tong; Thomas A D'Amico; Mark F Berry
Journal:  J Thorac Cardiovasc Surg       Date:  2012-11-21       Impact factor: 5.209

6.  The safe transition from open to thoracoscopic lobectomy: a 5-year experience.

Authors:  Christopher W Seder; Kenny Hanna; Victoria Lucia; Judith Boura; Sang W Kim; Robert J Welsh; Gary W Chmielewski
Journal:  Ann Thorac Surg       Date:  2009-07       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.